期刊文献+

超声与钼靶X线检查对早期乳腺肿瘤的诊断价值比较 被引量:6

原文传递
导出
摘要 目的:比较超声与钼靶X线检查对早期乳腺肿瘤的诊断价值。方法乳腺癌患者80例,分别进行高频彩超及X线钼靶同期检查,对比分析两者对早期乳腺肿瘤的诊断价值。结果高频超声对早期乳腺肿瘤的诊断准确率为87.5%,钼靶X线诊断准确率为71.3%,超声联合钼靶X线诊断准确率为92.5%。超声检查结果显示,形态不规则58例,边界不清晰65例,55例均为低回声,回声分布不均匀,肿块后方回声衰减或消失58例,增强5例,40例肿块周围厚薄不均强回声带包绕。钼靶X线检查显示,边缘不清晰60例,肿块内密度不均匀42例,分叶29例,毛刺22例,大部分毛刺较短或呈小突起状,肿块内钙化59例,呈小片针状钙化阴影;厚皮征、牛角征24例。结论高频超声和钼靶X线检查均具有典型的影像学特征,高频超声诊断早期乳腺肿瘤的正确性优于钼靶X线,但各有优缺点,两者联合并结合临床资料进行诊断,将有助于提高早期乳腺肿瘤的诊断率。
作者 俞芳 黄声岳
出处 《中国基层医药》 CAS 2015年第7期1082-1083,共2页 Chinese Journal of Primary Medicine and Pharmacy
  • 相关文献

参考文献15

二级参考文献118

共引文献382

同被引文献59

  • 1尹益民,任晓萍,潘文倩,艾红.高频超声及钼靶X线检查在乳腺癌诊断中的应用价值[J].西安交通大学学报(医学版),2012,33(5):572-575. 被引量:79
  • 2洪常华,韩德昌,杨新宇,姬颖彬,田震静,吴玉辉,侯坤.乳腺MRI与乳腺X线诊断导管原位癌的临床效果[J].中国老年学杂志,2015,35(2):376-377. 被引量:12
  • 3Gianni L, Pienkowski T, Im Y H, et al. Efficacy and safety ofneoadjuvant pertuzumab and trastuzumab in women with locally advanced inflammatory or early HER2-positive breast cancer (NeoSphere) : arandomised multicentre open-label phase 2 trial [ J ]. Lancet Oncol, 2012,13 ( 1 ) :25-32.
  • 4Gianni L, Eiermann W J, Semiglazov V, et al. Neoad ju-vant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone in patients with HER2-positive locally advanced breast canc- er(the NOAH trial) :A randomised controlled superiority trial with aparallel HER2-uegative cohort [ J ]. Lancet, 2010,15(6) :375-377.
  • 5Lari S A, Kuerer H M. Biological markers in DCIS and risk of breast recurrence: a systematic review[ J]. Cancer 2011,2( 1 ) :232-261.
  • 6Albonico G, Querzoli P, Ferretti S, et al. Biological pro- file of in situ breast cancer investigated by immunohisto- chemical technique [ J]. Cancer Detect Prey, 1998,22 (4) :313-318.
  • 7Elledge R M, Allred D C. The p53 tumor suppressor gene in breast cancer[ J]. Breast Cancer Res Treatment , 1994,32( 1 ) :39-47.
  • 8Landoni V, Francione V, Marzi S, et al. Quantitative analysis of elastography imagoes in the detection of breast caneer[ J ]. Eur J Radiol,2012,81 (7) : 1527-1531.
  • 9Hoyt K, Sorace A, Saini R, et al..Volumetric contrast-enhanced ultrasound imaging to assess early response to apop-tosis-inducing anti-death receptor 5 antibody therapy in a breast cancer animal model[ J]. J Ultrasound Med, 2012,31 ( 11 ) : 1759-1766.
  • 10Gruber R, Jaromi S, Rudas M, et al. The Histologic work-up of non-palpable breast lesions classified as probably benign at initial mammography and/or ultrasound( BI-RADS category 3 ) [ J]. Eur J Radiol,2013,82 ( 3 ) : 398-403.

引证文献6

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部